| For: | Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i45/7088.htm |
| Number | Citing Articles |
| 1 |
Yingying Lin, Yuefei Ma, Yan Chen, Yepei Huang, Jinchuan Lin, Zhenzhou Xiao, Zhaolei Cui. Diagnostic and prognostic performance of serum GPC3 and PIVKA-II in AFP-negative hepatocellular carcinoma and establishment of nomogram prediction models. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14025-y
|
| 2 |
Ka Zhang, Yifan Jia, Xin Shu, Xiaoan Yang, Haixia Sun, Hong Cao, Yongyu Mei, Canhui Xiao. Relationship Between Platelets and the Clinical Efficacy of Umbilical Cord Mesenchymal Stem Cells for HBV-Related Acute-on-Chronic Liver Failure and Liver Cirrhosis: A Preliminary Clinical Study. Stem Cells Translational Medicine 2023; 12(6) doi: 10.1093/stcltm/szad023
|
| 3 |
Nan Chen, Pengyu Luo, Yuna Tang, Pei Liu, Jing Wang, Yuchen Fan, Liyan Han, Kai Wang. Accelerators of chronic hepatitis B fibrosis cirrhosis CCND1 gene expression and promoter hypomethylation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93778-9
|
| 4 |
Wei-Dong Jia, Ming-Tong Wei, Xiang-Yi Bu, Jian-Lin Lu, Yong-Hai Li, Zi-Ling Xu, Gui-Xiang Qian. Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis. World Journal of Gastroenterology 2024; 30(15): 2128-2142 doi: 10.3748/wjg.v30.i15.2128
|
| 5 |
Lisa S. Parks, Patricia Little. Cirrhosis, Hepatocellular Carcinoma, and Locoregional Therapies. Journal of Radiology Nursing 2022; 41(2) doi: 10.1016/j.jradnu.2022.01.005
|
| 6 |
Yingying Zhao, Song Yang, Huichun Xing. Pulmonary Bacterial Infection and Liver Cirrhosis: Current Status and Treatment. Infectious Microbes and Diseases 2024; 6(1) doi: 10.1097/IM9.0000000000000137
|
| 7 |
Anton Gillessen, Francesco Angelico, Jun Chen, Lungen Lu, Maria Isabel Lucena, Qingchun Fu, Qing Xie, Raul J. Andrade, Wen Xie, Xiaoyuan Xu, Yanyan Yu, Yi-min Mao, Yuemin Nan. Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. Gastro Hep Advances 2022; 1(5) doi: 10.1016/j.gastha.2022.05.006
|
| 8 |
Zhiying He, Bingqiong Wang, Xiaoning Wu, Zhongjie Hu, Chunqing Zhang, Yanqin Hao, Yongfeng Yang, Yan Huang, Wei Rao, Jing Wang, Jialing Zhou, Shuai Xia, Xiaojuan Ou, Jidong Jia, Hong You. Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding. Hepatology International 2023; 17(6) doi: 10.1007/s12072-023-10579-w
|
| 9 |
Qian Yang, Hua Ye, Guiying Sun, Keyan Wang, Liping Dai, Cuipeng Qiu, Jianxiang Shi, Jicun Zhu, Xiao Wang, Peng Wang. Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. Molecular Oncology 2023; 17(5) doi: 10.1002/1878-0261.13371
|
| 10 |
Shan Tang, Xiaodan Zhang, Zhongping Duan, Manman Xu, Ming Kong, Sujun Zheng, Li Bai, Yu Chen. The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury. International Immunopharmacology 2023; 116 doi: 10.1016/j.intimp.2023.109808
|
| 11 |
Weiqiang Gan, Youming Chen, Zeqian Wu, Yingfu Zeng, Zhiliang Gao, Yongyu Mei. Characteristics of Patients with Cryptogenic Cirrhosis: A Retrospective Study. Diseases and Research 2021; 1(1) doi: 10.54457/DR.2021010004
|
| 12 |
Xiaojing Wu, Junqi Niu, Ying Shi. Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02544-y
|
| 13 |
Hui Liu, Yang Liu, Qiong Tian, Xiling Hu, Yide Li, Chunfei Wang, Keyu Guo. A Nomogram Prediction Model and Validation of Hypoglycemia Risk in Patients With Decompensated Cirrhosis and Type 2 Diabetes. Journal of Diabetes Research 2026; 2026(1) doi: 10.1155/jdr/6812038
|
| 14 |
Yijie Yan, Yue Li, Chunlei Fan, Yuening Zhang, Shibin Zhang, Zhi Wang, Tehui Huang, Zhenjia Ding, Keqin Hu, Lei Li, Huiguo Ding. A novel machine learning-based radiomic model for diagnosing high bleeding risk esophageal varices in cirrhotic patients. Hepatology International 2022; 16(2) doi: 10.1007/s12072-021-10292-6
|
| 15 |
Miaochan Wang, Yujiao Jin, Aifang Xu. Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis. Clinical Chemistry and Laboratory Medicine (CCLM) 2024; 62(2) doi: 10.1515/cclm-2023-0742
|
| 16 |
Xia Wan, Hua Xu, Hu Li, Shan Zhong, Yu Lei, Huan Deng, Xiao Fu, Zhi Zhou. Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03910-2
|
| 17 |
Siwei Yang, Xiuwan Ren, Xiaoqing Guo, Jianan Yu, Lizhen Niu, Yao Niu, Linpeng Zhang, Long Jin. Decreased Subcutaneous Adipose Tissue Correlates With Higher Portal Hypertension and Poor Survival in Patients With Cirrhosis: A Retrospective Binary-Center Study. Clinical and Translational Gastroenterology 2025; 16(5) doi: 10.14309/ctg.0000000000000836
|
| 18 |
Xiping Ran, Yang Xu, Ying Wang, Cheng Zeng, Chen Gong, Ni Wang, Dachuan Cai. Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1510939
|
| 19 |
Yue Xu, Qin Yin, Jiangqiang Xiao, Qing Zhao, Xiaotian Chen, Ming Zhang, Bo Gao. Impact of quantitative dietary guidance on postoperative outcomes in patients undergoing transjugular intrahepatic portosystemic shunt surgery: a retrospective cohort study. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1671392
|
| 20 |
Lei Xu, Lin Chen, Bin Zhang, Zhicheng Liu, Qiumeng Liu, Huifang Liang, Yifa Chen, Xiaoping Chen, Chao Leng, Bixiang Zhang. Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1115706
|
| 21 |
Kai Deng, Mei Juan Wang, Yong Cun Liu, Ming Wang. Correlation analysis of serum TIP30 mRNA expression with recompensation and short-term prognosis in the patients with hepatitis B virus-derived decompensated liver cirrhosis. Laboratory Medicine 2026; 57(1) doi: 10.1093/labmed/lmaf083
|
| 22 |
Rong Wang, Keying Jing, Yang Liu, Huijuan Zhao, Jun Cai. Viral hepatitis is associated with increased risk of decompensated cirrhosis or liver failure in patients positive for liver cytosol antibody type 1. Scandinavian Journal of Immunology 2023; 98(2) doi: 10.1111/sji.13281
|
| 23 |
Qiao Ke, Xueping Yu, Xuan Wang, Jinfa Huang, Biding Lin, Jian He, Zhiyong Wang, Xinhui Huang, Xiadi Weng, Yubin Jiao, Yixing Xie, Weimin Wu, Linbin Qiu, Ling Li, Zhengju Xu, Zhijun Su, Yuzhen Zhuge, Jingfeng Liu, Wuhua Guo. Prevalence, clinical characteristics, and outcomes of spontaneous portosystemic shunt in patients with hepatitis B-related cirrhosis: A multicenter study from China. Digestive and Liver Disease 2023; 55(10) doi: 10.1016/j.dld.2023.04.012
|
| 24 |
Xin Luo. Albumin ratio and liver-to-abdominal area ratio are promising prognostic indicators for patients with post-hepatitis B cirrhosis. American Journal of Translational Research 2025; 17(8) doi: 10.62347/KKMB6772
|
| 25 |
Di Meng, Shuang Ren. Mairin from Huangqi Decoction Mitigates Liver Cirrhosis through
Suppression of Pro-inflammatory Signaling Pathways: A Network
Pharmacology and Experimental Study. The Natural Products Journal 2024; 14(5) doi: 10.2174/0122103155273345231210170121
|
| 26 |
Mingshu Liu, Haifang Wang, Fei Shao, Yanfang Xu, Jing Huang, Huijie Zhang, Yaru Han. Effect of graded nursing based on the Glasgow-Blatchford score in liver cirrhosis patients complicated with acute upper gastrointestinal bleeding. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1679939
|
| 27 |
Dandan Zhao, Songhao Yu, Peilin Guo, Xiaoxiao Zhang, Yuhui Tang, Chen Dong, Suxian Zhao, Lu Li, Zaid Al‐Dhamin, Rong Ai, Ningning Xue, Shiming Dong, Yuemin Nan. Identification of potential plasma markers for hepatitis B virus‐related chronic hepatitis and liver fibrosis/cirrhosis. Journal of Medical Virology 2022; 94(8) doi: 10.1002/jmv.27761
|
| 28 |
Xiaohang Shan, Ping Huang, Wei Ye, Min Ai, Yongfeng Yang. Association between liver stiffness measurement and portal vein thrombosis among patients with cirrhosis: A cross-sectional study. Medicine 2025; 104(44) doi: 10.1097/MD.0000000000045520
|
| 29 |
Yu Su, Qianyi Wang, Xiaoyi Sun, Xinyu Zhao, Xinyan Zhao, Jidong Jia, Shan Shan. Serum immunoglobulin G levels in patients with cirrhosis due to autoimmune hepatitis or other etiologies. European Journal of Gastroenterology & Hepatology 2026; doi: 10.1097/MEG.0000000000003209
|
| 30 |
Zizhuo Wang, Songlin Song, Lijie Zhang, Tingting Yang, Wei Yao, Bin Liang. Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1474442
|
| 31 |
Xiang Li, Guodong Lv, Daolang Yuan, Jun Hu, Wenrong Lou, Yulin Tu, Jing Zhou, Rong Qin. Trained immunity as a systemic bridge: the liver-gut-immune-oral axis in the comorbidity of chronic liver disease and periodontitis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1855561
|
| 32 |
Yi-Wen Zhang, An-Lin Liu, Zhen Liu, Yun-Zhi Zhang, Ling Luo, Rong Chen. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension. World Journal of Gastroenterology 2024; 30(13): 1859-1870 doi: 10.3748/wjg.v30.i13.1859
|
| 33 |
Zhengyu Xu, Dawei Yang, Jia Luo, Hui Xu, Jidong Jia, Zhenghan Yang. Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis. Journal of Magnetic Resonance Imaging 2023; 58(5) doi: 10.1002/jmri.28690
|
| 34 |
Ruonan Sun, Jiawei Li, Xianyi Lin, Yidong Yang, Bing Liu, Tianbi Lan, Shuang Xiao, Anyi Deng, Zhinan Yin, Yan Xu, Zheng Xiang, Bin Wu. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1079495
|
| 35 |
Nan Chen, Yu Sun, Pengyu Luo, Yuna Tang, Yuchen Fan, Liyan Han, Kai Wang. Association of CXCR4 gene expression and promoter methylation with chronic hepatitis B-related fibrosis/cirrhosis. International Immunopharmacology 2024; 139 doi: 10.1016/j.intimp.2024.112686
|
| 36 |
Melchor Alpízar Salazar, Samantha Estefanía Olguín Reyes, Andrea Medina Estévez, Julieta Alejandra Saturno Lobos, Jesús Manuel De Aldecoa Castillo, Juan Carlos Carrera Aguas, Samary Alaniz Monreal, José Antonio Navarro Rodríguez, Dulce María Fernanda Alpízar Sánchez. Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma. Medicina 2025; 61(1) doi: 10.3390/medicina61010088
|
| 37 |
Jiayao Huang, Lu Yao, Qingyu Wu, Xiaoer Zhang, Dongming Li, Haiyi Long, Xian Zhong, Lili Chen, Xiaoyan Xie, Manxia Lin. The role of liver stiffness measurement in predicting Long-term liver function after partial hepatectomy. Abdominal Radiology 2025; doi: 10.1007/s00261-025-05324-w
|
| 38 |
Taiyu He, Yingzhi Zhou, Pan Xu, Ning Ling, Min Chen, Tianquan Huang, Biqiong Zhang, Ziqiao Yang, Ling Ao, Hu Li, Zhiwei Chen, Dazhi Zhang, Xiaofeng Shi, Yu Lei, Zhiyi Wang, Weiqun Zeng, Peng Hu, Yinghua Lan, Zhi Zhou, Juan Kang, Ying Huang, Tongdong Shi, Qingbo Pan, Qian Zhu, Xiping Ran, Yingzhi Zhang, Rui Song, Dejuan Xiang, Shuang Xiao, Gaoli Zhang, Wei Shen, Mingli Peng, Dachuan Cai, Hong Ren. Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection. Liver International 2022; 42(6) doi: 10.1111/liv.15173
|
| 39 |
Zhiying He, Jialing Zhou, Yu Tian, Shanshan Wu, Yameng Sun, Xiaojuan Ou, Jidong Jia, Bingqiong Wang, Xiaoning Wu, Hong You. Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis. Scandinavian Journal of Gastroenterology 2023; 58(4) doi: 10.1080/00365521.2022.2132532
|
| 40 |
Nan Geng, Ming Kong, Jiateng Zhang, Huina Chen, Manman Xu, Wenyan Song, Yu Chen, Zhongping Duan. Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64420-x
|
| 41 |
Qiao Ke, Jian He, Xinhui Huang, Ling Li, Jingfeng Liu, Wuhua Guo. Spontaneous portosystemic shunts outside the esophago-gastric region: Prevalence, clinical characteristics, and impact on mortality in cirrhotic patients: A systematic review and meta-analysis. European Journal of Internal Medicine 2023; 112 doi: 10.1016/j.ejim.2023.03.024
|
| 42 |
Wei-Guo Chen, Jian-Bo Zhao, Li-Zi Kun, Zhong-Yue Ou, Hui Zeng, Qing Tan, Qi-Feng Peng, Geng-Geng Qin, Wei-Xiong Zeng, Feng-Xia Zeng, Li-Xuan Jia, De-Jia Liu. Machine learning prediction of hepatic encephalopathy for long-term survival after transjugular intrahepatic portosystemic shunt in acute variceal bleeding. World Journal of Gastroenterology 2025; 31(4): 100401 doi: 10.3748/wjg.v31.i4.100401
Abstract(550) |
Core Tip(583) |
Full Article(HTML)(2043)
|
Full Article (PDF)-3968K(197)
|
Full Article with Cover (PDF)-4284K(182)
|
Full Article (XML)-109K(131)
|
Audio-580K(10)
|
Peer-Review Report-231K(113)
|
Answering Reviewers-168K(113)
|
Supplementary Material-402K(118)
|
Times Cited (7)
|
Total Visits (3467)
|
Open
|
| 43 |
Ke Shi, Xiaojing Wang, Zhang Yi, Yanqiu Li, Ying Feng, Xianbo Wang. Inflammatory lipid biomarkers and transplant-free mortality risk in hepatitis B-related cirrhosis and hepatic encephalopathy. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1528733
|
| 44 |
Qiao Ke, Zhiyong Wang, Xinhui Huang, Ling Li, Weimin Wu, Linbin Qiu, Yubin Jiao, Yixing Xie, Xiaosong Peng, Jingfeng Liu, Wuhua Guo. Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts. Annals of Hepatology 2022; 27(5) doi: 10.1016/j.aohep.2022.100725
|
| 45 |
Shanghao Liu, Jianzhong Ma, Ping Chen, Shirong Liu, Ying Guo, Mingjie Tan, Xiaoqing Guo, Yinong Feng, Qinghui Wang, Wenhua Li, Chengchen Yang, Bo Gao, Yongli Hua, Ning Liu, Haolin Song, Ruiling He, Ruiying Wang, Qi Gao, Chuan Liu, Xiaolong Qi. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis. Journal of Medical Virology 2024; 96(1) doi: 10.1002/jmv.29380
|
| 46 |
Wenling Wang, Xiaolin Wang, Yu Wu, Huaibin Zou, Manman Xu, Yu Chen. Risk factors for the development of cirrhosis within 1-year in non-cirrhotic patients with HBV- related acute-on-chronic liver failure. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1743728
|
| 47 |
Zhong-Ji Meng, Yuan-Yao Zhang. Definition and classification of acute-on-chronic liver diseases. World Journal of Clinical Cases 2022; 10(15): 4717-4725 doi: 10.12998/wjcc.v10.i15.4717
|
| 48 |
Dan-Tong Zhao, Hui-Ping Yan, Hui-Yu Liao, Yan-Min Liu, Ying Han, Hai-Ping Zhang, Wei-Ming Zhang, Chun-Yang Huang, Xiu-Hong Liu, Jin-Li Lou, Yan Zhao. Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1098076
|
| 49 |
Dan-Tong Zhao, Hui-Ping Yan, Ying Han, Wei-Ming Zhang, Yan Zhao, Hui-Yu Liao. Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1142177
|
| 50 |
Jin Cheng, Honglei Ju, Guixiang Wang, Chiyi He, Wei Wang. Association of Systemic Inflammation Response Index with Short-Term All-Cause Mortality in Decompensated Liver Cirrhosis Patients. Journal of Inflammation Research 2024; doi: 10.2147/JIR.S476743
|
| 51 |
Bing Zhu, Fu-Quan Liu, Yue-Ning Zhang, Hui-Guo Ding, Guang-De Zhou, Yong-Ping Yang, Jing-Hui Dong, Fu-Chuan Wang, Hua Tian, Dong-Ze Li, Ming-Ming Meng, Ying Han, Bo-Wen Liu, Yi-Fan Lv. Proposal of a new classification scheme for complete portal vein thrombosis and its clinical significance: A retrospective study. World Journal of Gastroenterology 2026; 32(17): 117479 doi: 10.3748/wjg.v32.i17.117479
Abstract(51) |
Core Tip(51) |
Full Article(HTML)(209)
|
Full Article (PDF)-5903K(155)
|
Full Article with Cover (PDF)-7381K(27)
|
Full Article (XML)-110K(17)
|
Audio-9576K(9)
|
Peer-Review Report-172K(28)
|
Answering Reviewers-229K(14)
|
Supplementary Material-148K(18)
|
Times Cited (0)
|
Total Visits (503)
|
Open
|
| 52 |
Da Zhou, Yifan Shi, Donghua Zhang, Junbo Zuo, Chenghao Zeng, Gulsudum Mamtawla, LongChang Huang, Xuejin Gao, Li Zhang, Xinying Wang. Liver-secreted FGF21 induces sarcopenia by inhibiting satellite cell myogenesis via klotho beta in decompensated cirrhosis. Redox Biology 2024; 76 doi: 10.1016/j.redox.2024.103333
|
| 53 |
Yanjing Wu, Yongle Wu, Kun Liu, Hui Liu, Shanshan Wang, Jian Huang, Huiguo Ding. Identification of Genetic Predisposition in Noncirrhotic Portal Hypertension Patients With Multiple Renal Cysts by Integrated Analysis of Whole-Genome and Single-Cell RNA Sequencing. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.775470
|
| 54 |
Ying Hao Cao, Ping Chi, Chen Zhou, Wen Fei Lv, Zhe Fen Quan, Fu Shan Xue. The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy. Journal of Clinical Pharmacy and Therapeutics 2022; 47(12) doi: 10.1111/jcpt.13751
|
| 55 |
Yan Li, Meng-Jun Zhang, Xue-Hong Wang, Su-Hua Li. Novel noninvasive indices for the assessment of liver fibrosis in primary biliary cholangitis. Biomedical Reports 2023; 20(1) doi: 10.3892/br.2023.1689
|
| 56 |
Junwei Huang, Yiming Tao, Jianguo Yao, Xiaorui Song, Yiming Li, Yiting Yuan. Metabolic syndrome is associated with worse prognosis in elderly patients with hepatocellular carcinoma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1542328
|
| 57 |
Qi Li, Qikun Zhang, Zhao Liu, Lingna Lyu, Chunlei Fan, Huiguo Ding, Jin Chai. Short‐Term Mortality Rate and Predictors for Older Patients With Liver Cirrhosis–Associated Acute Upper Gastrointestinal Bleeding. International Journal of Clinical Practice 2025; 2025(1) doi: 10.1155/ijcp/6615949
|
| 58 |
Caie Wang, Yiyang Shang, Ghid Kanaan, Lu Chai, Hui Li, Xingshun Qi. Silymarin for adults with metabolic dysfunction-associated steatotic liver disease. Cochrane Database of Systematic Reviews 2025; 2025(6) doi: 10.1002/14651858.CD015524.pub2
|
| 59 |
Chunjiao Yu, Fan Ni, Mengyao Zheng, Zhaoda Duan, Wenjie Yang, Man Huang, Hongyan Xu, Mengyu Li, Shunyu Chen, Chaozhang Gu, Jinhui Yang, Jianjun Liu, Hongtao Lei, Shan Yan. Impact of the prognostic nutritional index on the recompensation of patients with decompensated primary biliary cholangitis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1605380
|
| 60 |
Caie Wang, Ghid Kanaan, Yiyang Shang, Lu Chai, Hui Li, Xingshun Qi. Silymarin for treatment of adults with nonalcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2023; 2023(4) doi: 10.1002/14651858.CD015524
|
| 61 |
Dianqiang Lu, Zhengyan Jiang, Xuezhen Zhai, Zhiguang Sun, Ahmed Faeq Hussein. Prognostic Analysis of Liver Cirrhosis Patients with Cerebral Infarction and/or Gastrointestinal Hemorrhage: A Retrospective Cohort Study. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/2566746
|
| 62 |
Yuanxun Yue, Zhizhong Ren, Yaqin Wang, Ying Liu, Xiaowei Yang, Tianxiao Wang, Yating Bai, He Zhou, Qian Chen, Sujun Li, Yuewei Zhang. Impact of Microparticle Transarterial Chemoembolization (mTACE) on myeloid‐derived suppressor cell subtypes in hepatocellular carcinoma: Clinical correlations and therapeutic implications. Immunity, Inflammation and Disease 2024; 12(9) doi: 10.1002/iid3.70007
|
| 63 |
Jie Cheng, Kai Huang, Juan-Li Mou, Yao-Jia Lao, Jia-Hui Feng, Fan Hu, Meng-Lu Lin, Tangnuer Maimaitiaishan, Jian Shang, Jun Lin. Prognosis value of serum chloride on 1-year mortality in cirrhotic patients receiving transjugular intrahepatic portosystemic shunt. Journal of the Formosan Medical Association 2023; 122(9) doi: 10.1016/j.jfma.2023.02.009
|
| 64 |
Zhou Yu, Dongmei Chen, Yansong Zheng, Xuedan Wang, Shuna Huang, Tiansheng Lin, Yihan Lin, Yanfang Zhang, Yingna Huang, Qishui Ou, Jinlan Huang. Development and validation of a diagnostic model for AFP-negative hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(13) doi: 10.1007/s00432-023-04997-4
|
| 65 |
Zehong Wang, Xuanxuan Wang, Li Zhou, Shaoyuan Shi, Yongli Hua, Yinong Feng. Safety and efficacy of 48-week pegylated interferon-α-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1489671
|
| 66 |
Fengbin Zhang, Yonghe Zhou, Xin Li, Chunyan Wang, Jie Liu, Shuang Li, Shuting Zhang, Weiming Luo, Lili Zhao, Jia Li. Spleen Thickness Plus Platelets Can Effectively and Safely Screen for High-Risk Varices in Cirrhosis Patients. Diagnostics 2023; 13(20) doi: 10.3390/diagnostics13203164
|
| 67 |
Qi Li, Ruifeng Liu, Shenghui Zhou, Lingna Lyu, Chunlei Fan, Huiguo Ding. Endoscopic treatment as secondary prophylaxis ameliorates short-term mortality for acute esophagogastric variceal bleeding in older patients with cirrhotic hepatocellular carcinoma. Therapeutic Advances in Chronic Disease 2025; 16 doi: 10.1177/20406223251356824
|
| 68 |
Xiao K. Ran, Xiao F. Zhao, Zhen W. Wei, Hua Z. Pang, Yan F. Tang, Rong Liu, Tie X. Wu, Xu D. Liu. Circle-seq reveals that eccDNA may be a key blood biomarker for HBV-associated liver cancer. Frontiers in Genetics 2025; 15 doi: 10.3389/fgene.2024.1454153
|
| 69 |
Xue-Fei Wei, Jin-Yu Zhu, Hui-Hui Liu, Xing Su, Ji-Hui Li, Yu-Chen Fan, Kai Wang. Hypomethylation of Tumor necrosis factor-like cytokine 1A(TL1A) and its decoy receptor 3 expressive level increase has diagnostic value in HBV-associated cirrhosis. Virology 2023; 585 doi: 10.1016/j.virol.2023.04.009
|
| 70 |
Yinping Zhai, Darong Hai, Li Zeng, Chenyan Lin, Xinru Tan, Zefei Mo, Qijia Tao, Wenhui Li, Xiaowei Xu, Qi Zhao, Jianwei Shuai, Jingye Pan. Artificial intelligence-based evaluation of prognosis in cirrhosis. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05726-2
|
| 71 |
Dan Zhou, Kunyi Ba, Tingting Jia, Yi Shen, Li Yang, Michele Molinari. Recompensation of Liver Cirrhosis: Definition, Mechanism, Etiological Differences, Prognosis, and Challenges. Canadian Journal of Gastroenterology and Hepatology 2026; 2026(1) doi: 10.1155/cjgh/8512168
|
| 72 |
Yingjun Chen, Shaoxian Chen, Chandi Xu, Li Yu, Shanshan Chu, Jianzhi Bao, Jinwei Wang, Junwei Wang. Identification of Diagnostic Biomarkers for Compensatory Liver Cirrhosis Based on Gut Microbiota and Urine Metabolomics Analyses. Molecular Biotechnology 2024; 66(11) doi: 10.1007/s12033-023-00922-9
|
| 73 |
Ke Shi, Lina Sun, Ying Feng, Xianbo Wang. Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1560564
|
| 74 |
Qi Li, Ruifeng Liu, Shenghui Zhou, Lingna Lyu, Chunlei Fan, Huiguo Ding. Age as a key predictor of 6-week mortality in cirrhotic patients with acute gastrointestinal bleeding: a retrospective cohort study. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1709816
|
| 75 |
Chen Hui-ling, Huang Kang-ming, Zhao Yu, Deng Yin-han, Du Huang, Xiao Shu-ping, Chen Hong-bin. The potential value of serum GP73 in the ancillary diagnosis and grading of liver cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 2023; 83(2) doi: 10.1080/00365513.2023.2175238
|
| 76 |
Yuan Xu, Bei Zhang, Fan Zhou, Ying-ping Yi, Xin-Lei Yang, Xiao Ouyang, Hui Hu. Development of machine learning-based personalized predictive models for risk evaluation of hepatocellular carcinoma in hepatitis B virus-related cirrhosis patients with low levels of serum alpha-fetoprotein. Annals of Hepatology 2024; 29(6) doi: 10.1016/j.aohep.2024.101540
|
| 77 |
Li Siyu, Yuan Yuan, An Ran, Li Minyan. Frailty as tested by the Liver Frailty Index in out-patient patients with cirrhosis in China: a cross-sectional study. European Journal of Gastroenterology & Hepatology 2023; 35(4) doi: 10.1097/MEG.0000000000002502
|
| 78 |
Yujiao Jin, Miaochan Wang, Yuan Liu, Aifang Xu. Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis. Medicine 2023; 102(42) doi: 10.1097/MD.0000000000035617
|
| 79 |
Haoyu Wang, Fuquan Liu. Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt. iLIVER 2023; 2(1) doi: 10.1016/j.iliver.2023.02.001
|
| 80 |
Wei-Jia Liao, Hong-Song Chen, Ting-Feng Xu, Li-Ying Ren, Bi-Geng Zhao, Pu Chen, Wan-Ying Qin, Dong-Bo Chen, Wei Dang, Jun Li, Min-Jun Liao. Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China. World Journal of Gastroenterology 2022; 28(27): 3503-3513 doi: 10.3748/wjg.v28.i27.3503
|
| 81 |
Xu Chen, Abdul Fatawu Mohammed, Chengbin Li. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma. Clinical and Applied Thrombosis/Hemostasis 2024; 30 doi: 10.1177/10760296231221535
|
| 82 |
Faming Shu, Ying Huang, Kan Zhang, Yong Lin, Jiongfen Li, Fuli Long, Dewen Mao, Na Wang. Integrated analysis of transcriptome and metabolome reveals key metabolites-related genes in chronic liver failure. Genomics 2026; 118(4) doi: 10.1016/j.ygeno.2026.111261
|
| 83 |
Fei-Hu Bai, Sheng-Juan Hu, Li Yao, Fang-Rui Hu, Rui-Juan Xin, Ming Luo. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy <i>via </i>the gut-liver-brain axis. World Journal of Gastroenterology 2023; 29(1): 144-156 doi: 10.3748/wjg.v29.i1.144
|
| 84 |
Zhihuai Wang, Peng Gao, Weijun Sun, Adeel ur Rehman, Jiakai Jiang, Suobao Xu, Cailin Xue, Chunfu Zhu, Xihu Qin. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.938102
|
| 85 |
O. Yu. Spasskaya, A. M. Gorbacheva, E. E. Bibik, I. N. Tikhonov, A. K. Eremkina, A. V. Khairieva, E. E. Litvinova, N. G. Mokrysheva. Mineral disorders in patients with chronic liver disease. Part 2: management. Obesity and metabolism 2026; 23(1) doi: 10.14341/omet13290
|